Epidemiology of interstitial lung disease in patients with metastatic breast cancer at baseline and after treatment with HER2-directed therapy: a real-world data analysis

PURPOSE: Using real-world data, interstitial lung disease (ILD) prevalence before and after HER2-directed therapy was estimated. Potential ILD risk factors in patients receiving HER2-directed therapy for metastatic breast cancer (mBC) were evaluated. METHODS: Adults with HER2-directed therapy for mB...

Descripción completa

Detalles Bibliográficos
Autores principales: Law, Jeanna Wallenta, Campbell, Alicyn, Weller, Colin, Johanson, Colden, Broome, Ronda, Piault, Elisabeth, Izano, Monika, Schrag, Andrew, Tran, Mary, Brown, Thomas D., Kaplan, Henry G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633512/
https://www.ncbi.nlm.nih.gov/pubmed/36201127
http://dx.doi.org/10.1007/s10549-022-06738-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633512/
https://www.ncbi.nlm.nih.gov/pubmed/36201127
http://dx.doi.org/10.1007/s10549-022-06738-6

Ejemplares similares